Squarepoint Ops LLC Mersana Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 81,629 shares of MRSN stock, worth $132,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,629

Previous 252,804 67.71%

Holding current value

$132,238

Previous $508,000 69.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.23 - $2.25 $210,545 - $385,143	-171,175 Reduced 67.71%	81,629 $154,000
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $505,608 - $1.12 Million	252,804 New	252,804 $508,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $449,057 - $946,661	-404,556 Reduced 96.73%	13,668 $31,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $1.25 Million - $3.88 Million	405,988 Added 3317.98%	418,224 $1.38 Million
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $341,280 - $598,946	-85,320 Reduced 87.46%	12,236 $50,000
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $464,260 - $645,856	82,170 Added 534.06%	97,556 $571,000
Q3 2022 Nov 14, 2022	SELL	$4.63 - $8.0 $976,865 - $1.69 Million	-210,986 Reduced 93.2%	15,386 $104,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $745,855 - $1.31 Million	-262,625 Reduced 53.71%	226,372 $1.05 Million
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $1.58 Million - $2.8 Million	422,325 Added 633.44%	488,997 $1.95 Million
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $365,362 - $657,385	66,672 New	66,672 $415,000
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $363,859 - $615,076	-42,507 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.28 - $18.07 $171,418 - $233,247	-12,908 Reduced 23.29%	42,507 $577,000
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $156,590 - $271,246	10,228 Added 22.63%	55,415 $897,000
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $429,285 - $703,324	25,492 Added 129.43%	45,187 $1.2 Million
Q3 2020 Nov 16, 2020	SELL	$16.2 - $25.7 $101,169 - $160,496	-6,245 Reduced 24.07%	19,695 $367,000
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $72,537 - $323,926	13,843 Added 114.43%	25,940 $607,000
Q1 2020 May 15, 2020	BUY	$4.41 - $9.28 $53,347 - $112,260	12,097 New	12,097 $71,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $157M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Mersana Therapeutics, Inc. Transaction History